These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 1465128

  • 1. Atherogenesis in transgenic mice expressing human apolipoprotein(a).
    Lawn RM, Wade DP, Hammer RE, Chiesa G, Verstuyft JG, Rubin EM.
    Nature; 1992 Dec 17; 360(6405):670-2. PubMed ID: 1465128
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.
    Rubin EM, Krauss RM, Spangler EA, Verstuyft JG, Clift SM.
    Nature; 1991 Sep 19; 353(6341):265-7. PubMed ID: 1910153
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall.
    Shimano H, Ohsuga J, Shimada M, Namba Y, Gotoda T, Harada K, Katsuki M, Yazaki Y, Yamada N.
    J Clin Invest; 1995 Feb 19; 95(2):469-76. PubMed ID: 7860728
    [Abstract] [Full Text] [Related]

  • 4. Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice.
    Grainger DJ, Kemp PR, Liu AC, Lawn RM, Metcalfe JC.
    Nature; 1994 Aug 11; 370(6489):460-2. PubMed ID: 8047165
    [Abstract] [Full Text] [Related]

  • 5. Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models.
    Boffa MB, Marcovina SM, Koschinsky ML.
    Clin Biochem; 2004 May 11; 37(5):333-43. PubMed ID: 15087247
    [Abstract] [Full Text] [Related]

  • 6. Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a).
    Callow MJ, Verstuyft J, Tangirala R, Palinski W, Rubin EM.
    J Clin Invest; 1995 Sep 11; 96(3):1639-46. PubMed ID: 7657833
    [Abstract] [Full Text] [Related]

  • 7. Lipoprotein(a) promotes smooth muscle cell proliferation and dedifferentiation in atherosclerotic lesions of human apo(a) transgenic rabbits.
    Ichikawa T, Unoki H, Sun H, Shimoyamada H, Marcovina S, Shikama H, Watanabe T, Fan J.
    Am J Pathol; 2002 Jan 11; 160(1):227-36. PubMed ID: 11786416
    [Abstract] [Full Text] [Related]

  • 8. Alcohol feeding impedes early atherosclerosis in low-density lipoprotein receptor knockout mice: factors in addition to high-density lipoprotein-apolipoprotein A1 are involved.
    Dai J, Miller BA, Lin RC.
    Alcohol Clin Exp Res; 1997 Feb 11; 21(1):11-8. PubMed ID: 9046367
    [Abstract] [Full Text] [Related]

  • 9. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM, Lee SJ, Kuriakose G, Spencer C, Becker L, Grosskopf I, Ko C, Huang LS, Koschinsky ML, Cooper AD, Tabas I.
    Arterioscler Thromb Vasc Biol; 2005 Aug 11; 25(8):1704-10. PubMed ID: 15905467
    [Abstract] [Full Text] [Related]

  • 10. Relative contributions of apolipoprotein(a) and apolipoprotein-B to the development of fatty lesions in the proximal aorta of mice.
    Mancini FP, Newland DL, Mooser V, Murata J, Marcovina S, Young SG, Hammer RE, Sanan DA, Hobbs HH.
    Arterioscler Thromb Vasc Biol; 1995 Nov 11; 15(11):1911-6. PubMed ID: 7583571
    [Abstract] [Full Text] [Related]

  • 11. Transgenic rabbits expressing human apolipoprotein (a).
    Fan J, Watanabe T.
    J Atheroscler Thromb; 2000 Nov 11; 7(1):8-13. PubMed ID: 11425047
    [Abstract] [Full Text] [Related]

  • 12. The effects of second-hand smoke on biological processes important in atherogenesis.
    Yuan H, Wong LS, Bhattacharya M, Ma C, Zafarani M, Yao M, Schneider M, Pitas RE, Martins-Green M.
    BMC Cardiovasc Disord; 2007 Jan 08; 7():1. PubMed ID: 17210084
    [Abstract] [Full Text] [Related]

  • 13. The apolipoprotein(a) gene: characterization of 5' flanking regions and expression in transgenic mice.
    Lawn RM.
    Chem Phys Lipids; 1994 Jan 08; 67-68():19-23. PubMed ID: 8187213
    [Abstract] [Full Text] [Related]

  • 14. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.
    Skålén K, Gustafsson M, Rydberg EK, Hultén LM, Wiklund O, Innerarity TL, Borén J.
    Nature; 2002 Jun 13; 417(6890):750-4. PubMed ID: 12066187
    [Abstract] [Full Text] [Related]

  • 15. Lipoprotein(a), plasmin modulation, and atherogenesis.
    Harpel PC, Hermann A, Zhang X, Ostfeld I, Borth W.
    Thromb Haemost; 1995 Jul 13; 74(1):382-6. PubMed ID: 8578490
    [Abstract] [Full Text] [Related]

  • 16. Fibrinogen deficiency reduces vascular accumulation of apolipoprotein(a) and development of atherosclerosis in apolipoprotein(a) transgenic mice.
    Lou XJ, Boonmark NW, Horrigan FT, Degen JL, Lawn RM.
    Proc Natl Acad Sci U S A; 1998 Oct 13; 95(21):12591-5. PubMed ID: 9770530
    [Abstract] [Full Text] [Related]

  • 17. Arterial hardening in mice.
    Scott J.
    Nature; 1992 Dec 17; 360(6405):631-2. PubMed ID: 1465121
    [No Abstract] [Full Text] [Related]

  • 18. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100.
    Gabel BR, Koschinsky ML.
    Biochemistry; 1998 May 26; 37(21):7892-8. PubMed ID: 9601051
    [Abstract] [Full Text] [Related]

  • 19. [Apolipoprotein (a)].
    Okubo M.
    Nihon Rinsho; 1994 Dec 26; 52(12):3133-8. PubMed ID: 7853701
    [Abstract] [Full Text] [Related]

  • 20. Male-associated hypertension in LDL-R deficient mice.
    Trieu VN, Uckun FM.
    Biochem Biophys Res Commun; 1998 Jun 18; 247(2):277-9. PubMed ID: 9642116
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.